WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has acquired certain assets of N. Stenning & Co Ltd. Pty, its distribution partner for Teleflex’s surgical products in Australia. Included in the transaction are the N. Stenning surgical customer relationships throughout Australia and a team of surgical sales representatives who are now direct employees of Teleflex Australia.
The acquisition of assets from N. Stenning & Co Ltd. Pty is another example of Teleflex executing a strategy of converting select distributors to a direct sales model, enabling the company to sell and distribute its products on a direct basis to its end-customers. N. Stenning & Co Ltd. Pty started distributing Teleflex surgical products under the Pilling and Weck brands nearly 35 years ago.
“Combining the experienced N. Stenning team with our existing direct distribution organization in Australia will strengthen and leverage the Teleflex sales platform to support new surgical product growth,” said Benson Smith, Chairman, President and Chief Executive Officer. “At the same time, this accretive acquisition allows us to capture additional margin and to better understand the needs of our customers, enabling us to grow our surgical products business more effectively.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 12,200 people and serves healthcare providers worldwide. For additional information about Teleflex please refer to www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
